$1.35
-0.01 (-0.74%)
Open$1.37
Previous Close$1.36
Day High$1.43
Day Low$1.35
52W High$1.57
52W Low$0.39
Volume—
Avg Volume178.7K
Market Cap74.22M
P/E Ratio—
EPS$-0.30
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,835.6% upside
Current
$1.35
$1.35
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.5K | 153.3K | 15.27M |
| Net Income | -18,521,137 | -66,410,451 | 4.70M |
| Profit Margin | -51,035.7% | -48,483.9% | 30.8% |
| EBITDA | -17,476,609 | -66,146,528 | 6.30M |
| Free Cash Flow | — | — | 4.04M |
| Rev Growth | -74.9% | -74.9% | -3.4% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |